Browse
related articles
Novartis to supply Oman swine flu vaccines
- Oman: Sunday, September 06 - 2009 at 09:27
Thaiba Pharmacy, which represents Swiss-based Novartis in Oman, has said the drug maker was in final stage discussions with the Sultanate's Health Ministry to supply Celtura, its H1N1 vaccine, the Oman Observer has reported. The company has pledged an initial batch of 100,000 doses of Celtura for the first round of immunizations, targeting priority segments of the population. Novartis's could supply between 600,000 and one million doses of the vaccine, depending upon Oman's requirements, Thaiba Pharmacy said.
Related Content
Article Options
StaffSunday, September 06 - 2009 at 09:27 UAE local time (GMT+4)
Replication or redistribution in whole or in part is expressly prohibited without the prior written consent of AME Info FZ LLC / Emap Limited.
Disclaimer »
Articles in this section are primarily provided directly by the companies appearing or PR agencies which are solely responsible for the content. The companies concerned may use the above content on their respective web sites provided they link back to http://www.ameinfo.com
Any opinions, advice, statements, offers or other information expressed in this section of the AMEinfo.com Web site are those of the authors and do not necessarily reflect the views of AME Info FZ LLC / Emap Limited. AME Info FZ LLC / Emap Limited is not responsible or liable for the content, accuracy or reliability of any material, advice, opinion or statement in this section of the AMEinfo.com Web site.
For details about submitting your stories, please read the guide - all content published is subject to our terms and conditions
